Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trex Wind-Down Inc TMBRQ

Healthcare
Trex Wind-Down, Inc., formerly Timber Pharmaceuticals, Inc., has filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code and is winding down its business. The Company has no operation nor generates any revenue.


GREY:TMBRQ - Post by User

Trex Wind-Down Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by PressReleaseon Dec 14, 2022 8:30am
19 Views
Post# 35170341

New Press Release - Timber Pharmaceuticals to Host Investor Business Briefing: Milestone Achievements and Forward Outlook

New Press Release - Timber Pharmaceuticals to Host Investor Business Briefing: Milestone Achievements and Forward Outlook
Virtual Business Briefing With Q&A to be Webcast on December 20, 2022 at 10:30 am ETBASKING RIDGE, NJ, Dec. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and...read article.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities